BLS Pharmaceuticals Ltd (BLS)

Currency in AUD
1.180
0.000(0.00%)
Closed·
Advertisement
Unusual trading volume
BLS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.1101.200
52 wk Range
0.3301.210
Key Statistics
Bid/Ask
1.14 / 1.16
Prev. Close
1.18
Open
1.18
Day's Range
1.11-1.2
52 wk Range
0.33-1.21
Volume
606.73K
Average Volume (3m)
290.95K
1-Year Change
187.8049%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Cash flows can sufficiently cover interest payments

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
26/07/2026
EPS / Forecast
0.03 / --
Revenue / Forecast
22.5M / --
EPS Revisions
Last 90 days

Compare BLS to Peers and Sector

Metrics to compare
BLS
Peers
Sector
Relationship
P/E Ratio
17.0x−0.9x−0.3x
PEG Ratio
0.090.010.00
Price/Book
8.4x0.6x2.6x
Price / LTM Sales
3.5x1.0x3.0x
Upside (Analyst Target)
-75.3%53.8%
Fair Value Upside
Unlock22.2%8.6%Unlock

BLS Pharmaceuticals Limited manufactures, imports, exports, and supplies controlled drugs and prescription medicines in Australia, the United Kingdom, Europe, and Japan. It operates through Manufacture/Sales Australia, Plant Based/UK/EU/JPN/AUS, and Wholesale PCC/USA segments. The Manufacture/Sales Australia segment engages in the manufacture and wholesale supply of preventive and novel medicines, cannabis, psilocybin, and MDMA under BLS. The Plant Based/UK/EU/JPN/AUS segment manufactures and distributes consumer health and novel food products under the Dr Watson brand. The Wholesale PCC/USA segment is involved in wholesale of patented Probiotics for gastrointestinal health and immunity. It also provides contract manufacturing services; and storage and distribution services. The company was formerly known as Bioxyne Limited and changed its name to BLS Pharmaceuticals Limited in June 2026. BLS Pharmaceuticals Limited is headquartered in Sydney, Australia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
36.34M15.80%42.89M
Public Companies & Retail Investors
193.63M84.20%228.49M
Total
229.98M100.00%271.37M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kirkman Trading Ltd6.86%15,780,56018,621
Global CR Holdings Limited4.18%9,613,38211,344

FAQ

What Is the BLS Pharms (Sydney: BLS) Share Price Today?

The BLS Pharms stock price today is 1.180 AUD.

What Stock Exchange Does BLS Pharms (BLS) Trade On?

BLS Pharms is listed and trades on the Sydney Stock Exchange.

What Is the Ticker (Stock Symbol) for BLS Pharms?

The stock symbol (also called a 'ticker') for BLS Pharms is "BLS."

What Is the Current BLS Pharms Market Capitalisation?

As of today, BLS Pharms (Sydney: BLS) market cap is 271.760M AUD.

What Is BLS Pharms's (BLS) Earnings Per Share (TTM)?

The BLS Pharms EPS is currently 0.067 (Trailing Twelve Months).

When Is the Next BLS Pharms Earnings Date?

BLS Pharms's next earnings report will be released on 02/12/2026.

Is BLS a Buy or Sell From a Technical Analyst Perspective?

Based on today's BLS Pharms moving averages and other technical indicators, the daily buy/sell signal for BLS stock is Strong Buy.

How Many Times Has BLS Pharms Stock Split?

BLS Pharms has split 3 times. (See the BLS stock split history page for full effective split date and price information.)

What is the current trading status of BLS Pharms (Sydney: BLS)?

As of 11/09/2026, BLS Pharms (BLS) is trading at a share price of 1.180 AUD, with a previous close of 1.180 AUD. The stock has fluctuated within a day range of 1.110 AUD to 1.200 AUD, while its 52-week range spans from 0.330 AUD to 1.210 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.